Correction: EZH2 blockade reverses doxorubicin resistance by inducing metabolic vulnerability and enhancing DNA damage in breast cancer.

Authors

Xiaomin Wang, Yuhang Ding, Yunxiao Mai, Ruinan Li, Xinyu Shao, Wenlong Chen, Yiming Li, Luhaoxiang Liu, Haoran Wang, Kangkang Liu, Yuanjie Niu, Jianmin Li, Guoping Xu, Yang Zhao

Published in

Frontiers in pharmacology. Volume 17. Pages 1882446. Epub Jun 08, 2026.

Abstract

[This corrects the article DOI: 10.3389/fphar.2026.1786648.].

PMID:
42338971
Bibliographic data and abstract were imported from PubMed on 24 Jun 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.